DE68919650D1 - 3'-Hydroxysubstituiertes Benzoxazinorifamycinderivat, Verfahren zu seiner Herstellung und dieses enthaltendes antibakterielles Mittel. - Google Patents

3'-Hydroxysubstituiertes Benzoxazinorifamycinderivat, Verfahren zu seiner Herstellung und dieses enthaltendes antibakterielles Mittel.

Info

Publication number
DE68919650D1
DE68919650D1 DE68919650T DE68919650T DE68919650D1 DE 68919650 D1 DE68919650 D1 DE 68919650D1 DE 68919650 T DE68919650 T DE 68919650T DE 68919650 T DE68919650 T DE 68919650T DE 68919650 D1 DE68919650 D1 DE 68919650D1
Authority
DE
Germany
Prior art keywords
derivative
preparation
same
antibacterial agent
agent containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68919650T
Other languages
English (en)
Other versions
DE68919650T2 (de
Inventor
Takehiko Yamane
Takuji Hashizume
Katsuji Yamashita
Kazunori Hosoe
Fumiyuki Kuze
Kiyoshi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Application granted granted Critical
Publication of DE68919650D1 publication Critical patent/DE68919650D1/de
Publication of DE68919650T2 publication Critical patent/DE68919650T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE68919650T 1988-11-01 1989-09-14 3'-Hydroxysubstituiertes Benzoxazinorifamycinderivat, Verfahren zu seiner Herstellung und dieses enthaltendes antibakterielles Mittel. Expired - Lifetime DE68919650T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27666188 1988-11-01
JP8039689 1989-03-30

Publications (2)

Publication Number Publication Date
DE68919650D1 true DE68919650D1 (de) 1995-01-12
DE68919650T2 DE68919650T2 (de) 1995-04-06

Family

ID=26421409

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68919650T Expired - Lifetime DE68919650T2 (de) 1988-11-01 1989-09-14 3'-Hydroxysubstituiertes Benzoxazinorifamycinderivat, Verfahren zu seiner Herstellung und dieses enthaltendes antibakterielles Mittel.

Country Status (6)

Country Link
US (1) US4983602A (de)
EP (1) EP0366914B1 (de)
CN (1) CN1023321C (de)
CA (1) CA1304363C (de)
DE (1) DE68919650T2 (de)
ES (1) ES2068862T3 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0787494B1 (de) * 1995-09-01 2004-06-09 Kaneka Corporation Verwendung eines Rifamycin-Derivates zur Herstellung eines Medikamentes zur Behandlung von Krankheiten verursacht durch Helicobacter pylori-Infektionen
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
JP3963976B2 (ja) * 1995-12-08 2007-08-22 株式会社カネカ クラミジア感染症治療剤
DE69829905T2 (de) * 1997-02-28 2006-03-09 Kaneka Corp. Heilmittel für durch Helicobacter verursachte Krankheit
EP1001778B1 (de) * 1997-07-29 2003-07-09 Kaneka Corporation Verwendung eines rifamycinderivates zur behandlung von mastitis bei tieren
US6486161B1 (en) 1998-07-29 2002-11-26 Kaneka Corporation Use of rifamycin derivative for treating mastitis in a domestic animal
US6316433B1 (en) 1998-12-18 2001-11-13 Kaneka Corporation Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
EP1511753A4 (de) * 2001-09-06 2005-10-12 Activbiotics Inc Antimikrobielle mittel und ihre verwendung
WO2003045319A2 (en) * 2001-11-21 2003-06-05 Activbiotics, Inc. Targeted therapeutics and uses thereof
AU2002364562A1 (en) * 2001-12-13 2003-06-30 Activbiotics, Inc. Metal complexes and formulations of rifamycin analogues and uses therof
US7078399B2 (en) * 2001-12-13 2006-07-18 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
US20090149453A1 (en) * 2002-05-23 2009-06-11 Activbiotics Pharma Llc Methods and compositions for treating bacterial infections and diseases associated therewith
US20040077533A1 (en) * 2002-05-23 2004-04-22 Sayada Chalom B. Methods and compositions for treating bacterial infections and diseases associated therewith
EP1531828A4 (de) * 2002-05-23 2005-11-02 Activbiotics Inc Verfahren zur behandlung von bakterieninfektionen und damit zusammenhängenden erkrankungen
US20040106590A1 (en) * 2002-08-29 2004-06-03 Barry Eisenstein Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
TW200418485A (en) * 2002-09-23 2004-10-01 Activbiotics Inc Rifalazil compositions and therapeutic regimens
WO2004054548A1 (en) * 2002-12-12 2004-07-01 Activbiotics,Inc. Method and reagents for treating or preventing atherosclerosis and diseases associated therewith
WO2004054513A2 (en) * 2002-12-12 2004-07-01 Activbiotics, Inc. Methods and compositions for treating and preventing ear infections
AU2004268531A1 (en) * 2003-08-22 2005-03-10 Activbiotics, Inc. Rifamycin analogs and uses thereof
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
JP2007506782A (ja) 2003-09-25 2007-03-22 アクティブバイオティクス インコーポレイティッド リファラジル製剤
AU2004298983A1 (en) * 2003-12-10 2005-06-30 Activbiotics, Inc. Rifamycin analogs and uses thereof
AU2004308399A1 (en) * 2003-12-23 2005-07-14 Activbiotics, Inc. Rifamycin analogs and uses thereof
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
BRPI0614758A2 (pt) 2005-08-11 2011-04-12 Targanta Therapeutics Inc rifamicinas fosfonadas e usos destas para a prevenção e tratamento de infecções na articulação e osso
MX2008012844A (es) * 2006-04-06 2009-01-19 Activbiotics Pharma Llc Composiciones farmaceuticas y usos de ellas.
US7678791B2 (en) * 2006-07-12 2010-03-16 Cumbre Ip Ventures, L.P. Nitroheteroaryl-containing rifamycin derivatives
WO2009064792A1 (en) * 2007-11-16 2009-05-22 Cumbre Pharmaceuticals Inc. Quinolone carboxylic acid-substituted rifamycin derivatives
US20110117154A1 (en) * 2008-07-07 2011-05-19 Activbiotics Pharma, Llc Use of rifalazil to treat colonic disorders
US8524691B2 (en) 2008-08-13 2013-09-03 The Medicines Company Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
JP6469094B2 (ja) 2013-05-31 2019-02-13 ジェネンテック， インコーポレイテッド 抗細胞壁タイコ酸抗体及びコンジュゲート
BR112015029754A2 (pt) 2013-05-31 2017-09-26 Genentech Inc anticorpos anti-teicoico da parede e conjugados
US9803002B2 (en) 2013-05-31 2017-10-31 Genentench, Inc. Anti-wall teichoic antibodies and conjugates
US20170202850A1 (en) 2014-07-21 2017-07-20 Hiroaki Serizawa Ophthalmic compositions of rifamycins and uses thereof
CN107206102A (zh) 2014-12-03 2017-09-26 豪夫迈·罗氏有限公司 抗金黄色葡萄球菌抗体利福霉素缀合物及其用途
CN107249642A (zh) 2014-12-03 2017-10-13 豪夫迈·罗氏有限公司 抗金黄色葡萄球菌抗体利福霉素缀合物及其用途
AR107800A1 (es) 2016-03-04 2018-06-06 Genentech Inc Proceso para la preparación de un conjugado de anticuerpo-rifamicina
CN108047249A (zh) * 2017-12-21 2018-05-18 中国医药集团总公司四川抗菌素工业研究所 一种新型利福霉素衍生物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130099C (de) * 1963-10-11
US4005077A (en) * 1965-08-24 1977-01-25 Ciba-Geigy Corporation Antibiotically active compounds
JPS59231092A (ja) * 1983-06-11 1984-12-25 Kanebo Ltd フエノチアジン型リフアマイシンおよびその医薬用途
US4690919A (en) * 1984-01-04 1987-09-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
JPS63183587A (ja) * 1985-02-05 1988-07-28 Kanegafuchi Chem Ind Co Ltd ベンゾキサジノリフアマイシン誘導体
JP2544375B2 (ja) * 1986-07-14 1996-10-16 鐘淵化学工業株式会社 アルキル置換ベンゾキサジノリフアマイシン誘導体

Also Published As

Publication number Publication date
DE68919650T2 (de) 1995-04-06
ES2068862T3 (es) 1995-05-01
EP0366914A2 (de) 1990-05-09
CA1304363C (en) 1992-06-30
CN1023321C (zh) 1993-12-29
US4983602A (en) 1991-01-08
EP0366914A3 (de) 1991-07-17
CN1042357A (zh) 1990-05-23
EP0366914B1 (de) 1994-11-30

Similar Documents

Publication Publication Date Title
DE68919650D1 (de) 3'-Hydroxysubstituiertes Benzoxazinorifamycinderivat, Verfahren zu seiner Herstellung und dieses enthaltendes antibakterielles Mittel.
DE3750749D1 (de) Modifiziertes Dienpolymer und Verfahren zu seiner Herstellung.
DE68920963D1 (de) Aralkylamin-Derivate, deren Herstellung und diese enthaltende fungizide Mittel.
DE3882461D1 (de) Retroreflektierendes ueberzugsmittel und zusammensetzung zu seiner herstellung.
DE69313010D1 (de) Dispergierbare Polydextrose, diese enthaltende Zusammensetzungen und Verfahren zu ihrer Herstellung
DE3787586D1 (de) Alkylsubstituiertes benzoxazinorifamycinderivat, verfahren zu seiner herstellung und dieses enthaltendes antibakterielles mittel.
DE68902767D1 (de) Flockgarn und verfahren zu seiner herstellung.
DE59108699D1 (de) Naphthylalkylaminopyrimidin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Schädlingsbekämpfungsmittel
DE3671451D1 (de) 4h-triazolo (4,3-a)(1,4) benzodiazepine, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
DE3888658D1 (de) Aromatisches Sulfid-Amid-Polymer und Verfahren zu seiner Herstellung.
DE3674582D1 (de) (s)-(-)-1-propyl-2',6'-pipecoloxylidid-hydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat.
DE69003121D1 (de) Filmbildendes Mittel.
DE58905246D1 (de) Heterocyclische substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
DE69027286D1 (de) Cephalosporin-Derivate, Verfahren zu ihrer Herstellung und diese Derivate enthaltende antimikrobielle Zusammensetzung
DE3667286D1 (de) Benzoxazinorifamycinderivat, verfahren zu seiner herstellung und diese enthaltende baktericide mittel.
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
DE3789466D1 (de) 3,7-Disubstituierte-3-Cephemverbindungen und Verfahren zu ihrer Herstellung.
DE69114420D1 (de) Organozyklosiloxane und Verfahren zu ihrer Herstellung.
DE68924722D1 (de) Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.
DE69106627D1 (de) Oligohexafluorpropylenverbindungen und Verfahren zu ihrer Herstellung.
DE69201964D1 (de) Phenoxyalkylcarbonsäurederivate, Verfahren zu ihrer Herstellung und anti-allergische Mittel.
DE69021602D1 (de) N-substituierte-3-Hydrazino-benzenesulfonamid-Derivate, Verfahren zu ihrer Herstellung und herbizide Mittel.
DE69019807D1 (de) Pyrimidindionderivate, Verfahren zu deren Herstellung und diese enthaltende antiarrhythmische Mittel.
DE3888529D1 (de) Tylosinderivate und Verfahren zu ihrer Herstellung.
DE69518934D1 (de) Antibiotikum WAP-8294A, Verfahren zu seiner Herstellung und antibakterielle Zusammensetzung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition